A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Public ClinicalTrials.gov record NCT07213791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose Escalation and Dose Optimization Phase 1a/1b Study to Evaluate Safety, Tolerability and Dosimetry of Radioligand Therapy With LY4337713 in Adults With FAP-Positive Solid Tumors (FiREBOLT)
Study identification
- NCT ID
- NCT07213791
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 241 participants
Conditions and interventions
Conditions
Interventions
- LY4337713 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 21, 2025
- Primary completion
- Jun 30, 2028
- Completion
- Feb 28, 2033
- Last update posted
- Apr 16, 2026
2025 – 2033
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | Recruiting |
| Stanford University Medical Center | Stanford | California | 94305 | Recruiting |
| Biogenix Molecular, LLC | Miami | Florida | 33165 | Recruiting |
| Moffitt | Tampa | Florida | 33612 | Not yet recruiting |
| Indiana University (IU) School of Medicine | Indianapolis | Indiana | 46202 | Recruiting |
| United Theranostics | Glen Burnie | Maryland | 21061 | Not yet recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Not yet recruiting |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | Not yet recruiting |
| BAMF Health Inc. | Grand Rapids | Michigan | 49503 | Recruiting |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | Not yet recruiting |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | Not yet recruiting |
| New York University (NYU) Clinical Cancer Center | New York | New York | 10016 | Not yet recruiting |
| David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Not yet recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | Not yet recruiting |
| Texas Oncology - DFW (Sammons CC) | Dallas | Texas | 75246 | Not yet recruiting |
| Baylor College of Medicine | Houston | Texas | 77030 | Not yet recruiting |
| University of Wisconsin - Carbone Cancer Center | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07213791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07213791 live on ClinicalTrials.gov.